Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAF^v600e mutated melanoma cells in vitro

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.